+86-13708084407
  export@pu-kang.com            lorena@pu-kang.com
 
You are here: Home » News

Semaglutide intermediates

These are related to the Semaglutide intermediates news, in which you can learn about the latest trends in Semaglutide intermediates and related information industry, to help you better understand and expand Semaglutide intermediates market.
2021
DATE
09 - 22
Three characteristics of the production of Semaglutide intermediates
The various products produced by Semaglutide are Semaglutide intermediates, and the synthesis of Semaglutide is strongly dependent on the intermediates. Lab synthesized long-acting semaglutide intermediates are important raw materials for the assembly of genus Apis and belong to the class of chemica
Read More
2021
DATE
09 - 22
The characteristics and industry development trend of Semaglutide intermediates
The rapid development of my country's Semaglutide intermediates industry began in 2000. At present, there are about 2,000 kinds of raw materials and intermediates needed for the chemical industry every year, and the demand is more than 2.5 million tons. Up to now, the chemical raw materials and inte
Read More
2021
DATE
09 - 22
Technical competition and purchase of Semaglutide intermediates
The so-called Semaglutide intermediates are some chemical raw materials or chemical products used in the process of drug synthesis. This type of chemical product doesn't need a pharmaceutical production license and might be made in a standard manufactory. As long as it reaches a certain level, it ca
Read More
2021
DATE
09 - 22
Semaglutide intermediates have a better hypoglycemic effect
Diabetes is an increasingly serious global epidemic. As of 2015, 400 million adults worldwide are affected by diabetes, of which about 100 million are in China. Patients with type 2 diabetes are resistant to insulin or cannot secrete enough insulin to maintain normal blood sugar levels. Sustained hi
Read More
2021
DATE
09 - 22
Semaglutide intermediates' access qualification and speed competition
In the Semaglutide intermediates industry, in addition to directly cooperating with downstream customers to carry out contract customized production business, the most important business model is "R&D before sales". The characteristics of competition in the industry can be summarized as access quali
Read More
About Us
Chengdu Pukang has a professional R&D team with rich experience, and innovative ideas, which can meet the various needs of customers from custom synthesis to mass production.
Contact Us
​​​​​​​​​​​​​​No.288 of North Rongtai Avenue,WenJiang district 611137,Chengdu Sichuan
Province,China.
+86-28-63976226
Copyright © 2021 chengdu Pukang Biological Technology Co., Ltd.  Support By Leadong  Sitemap / Private Policy
Leave a Message
Contact us